{
  "docId": "019dd923-5f69-752d-a9b7-cb9ca917cc95",
  "docSlug": "RKx0dsiKeHCYSDIkE7uF",
  "documentTitle": "Cyclica is already using AI to discover new medicines based on psychedelics. Here's the presentation the biotech startup used to raise a fresh $17 million.",
  "authorId": "Pitchdecks",
  "authorName": "Cyclica",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.78,
  "pageNumber": 5,
  "pageCount": 10,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide illustrates a workflow from ligand design to proteome screening and disease interaction mapping.",
  "elementsJson": [
    "paragraph",
    "process_diagram"
  ],
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5f69-752d-a9b7-cb9ca917cc95/5",
  "deckHref": "/decks/019dd923-5f69-752d-a9b7-cb9ca917cc95",
  "deckJsonHref": "/decks/019dd923-5f69-752d-a9b7-cb9ca917cc95.json",
  "deckAnchorHref": "/decks/019dd923-5f69-752d-a9b7-cb9ca917cc95#slide-5",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Our integrated drug discovery platform is powered by MatchMaker™, a deep learning model to identify drug-target interactions across the entire known proteome, and POEM™, a general purpose machine learning engine that has been implemented to design for ADMET properties.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-a28e-768f-b416-08f38fea6a92",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Ligand Design to Ligand Express workflow",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9922a773-b1d2-41a1-9750-4614e2371ce3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.88
      },
      "kind": "paragraph",
      "text": "Our integrated drug discovery platform is powered by MatchMaker™, a deep learning model to identify drug-target interactions across the entire known proteome, and POEM™, a general purpose machine learning engine that has been implemented to design for ADMET properties.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0e41ad89-ef7c-4590-b2d9-62f8bc81641d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.1
      },
      "kind": "paragraph",
      "text": "Our platform opens new opportunities for drug discovery, including multi-objective drug design, lead optimization, target deconvolution, and drug repurposing for small molecules, including PROTACS.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "797f0d91-da66-42ab-90cc-82de6b8a044d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 4,
      "beatId": "b36586bb-3d48-49ef-abf5-7c995f9584a4",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Slides 4-5 present Cyclica's platform and its capabilities.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 3,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "6deaf774-516a-46da-9cd4-8fce54352f51",
      "evidence": "The document implies that traditional AI in drug discovery companies are limited, and Cyclica's platform offers a more comprehensive solution.",
      "position": 0,
      "objective": "What is the cost of not adopting a more holistic approach to drug discovery?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}